[One and a half ventricular correction in the surgical treatment of congenital heart failure]

Insights

One and a half ventricular correction improved outcomes for congenital heart failure patients. This surgical technique supports the right ventricle and pulmonary circulation, creating better conditions for circulation in complex cases.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Congenital Heart Disease

Background:

  • Congenital heart failure (CHF) presents complex surgical challenges.
  • Traditional treatments may not fully address all aspects of complex CHF.
  • The need for innovative surgical approaches is critical.

Purpose of the Study:

  • To evaluate the efficacy of one and a half ventricular correction in treating congenital heart failure.
  • To analyze the role of this surgical method in the comprehensive treatment of CHF.
  • To explore the benefits of two-directional cavopulmonal anastomosis in complex CHF cases.

Main Methods:

  • Retrospective analysis of 54 operations for one and a half ventricular correction performed between 1999 and 2006.
  • Patient age ranged from 1 year 3 months to 29 years.
  • Inclusion of two-directional cavopulmonal anastomosis in specific complex CHF forms.

Main Results:

  • One and a half ventricular correction was successfully applied in 54 patients with congenital heart failure.
  • Two-directional cavopulmonal anastomosis effectively reduced volume load on the right ventricle.
  • The procedure created more favorable conditions for circulation by involving the hypoplastic and compromised right ventricle and pulmonary circulation.

Conclusions:

  • One and a half ventricular correction is a valuable surgical option for specific complex forms of congenital heart failure.
  • The technique, particularly with two-directional cavopulmonal anastomosis, enhances right ventricular support and improves circulatory conditions.
  • This approach offers a more favorable environment for radical correction in challenging pediatric cardiac cases.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...